171 related articles for article (PubMed ID: 38685125)
21. The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study.
Yang L; Lv Z; Xia W; Zhang W; Xin Y; Yuan H; Chen Y; Hu X; Lv Y; Xu Q; Weng X; Ni C
Clin Transl Oncol; 2018 Jul; 20(7):912-921. PubMed ID: 29243075
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
[TBL] [Abstract][Full Text] [Related]
24. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
25. Analysis of intrapatient heterogeneity of circulating tumor cells at the single-cell level in the cerebrospinal fluid of a patient with metastatic gastric cancer.
Cho JH; Sim MH; Kim SY; Kim K; Lee T; Lee J; Kang WK; Kim ST
J Cancer Res Ther; 2021; 17(4):1047-1051. PubMed ID: 34528562
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer.
Xie X; Wang L; Wang X; Fan WH; Qin Y; Lin X; Xie Z; Liu M; Ouyang M; Li S; Zhou C
Front Oncol; 2021; 11():672687. PubMed ID: 34055642
[TBL] [Abstract][Full Text] [Related]
27. Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice.
Milano A; Mazzetta F; Valente S; Ranieri D; Leone L; Botticelli A; Onesti CE; Lauro S; Raffa S; Torrisi MR; Marchetti P
Anal Cell Pathol (Amst); 2018; 2018():3506874. PubMed ID: 29682444
[TBL] [Abstract][Full Text] [Related]
28. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer.
Polioudaki H; Agelaki S; Chiotaki R; Politaki E; Mavroudis D; Matikas A; Georgoulias V; Theodoropoulos PA
BMC Cancer; 2015 May; 15():399. PubMed ID: 25962645
[TBL] [Abstract][Full Text] [Related]
29. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
30. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
31. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
[TBL] [Abstract][Full Text] [Related]
32. Universal marker and detection tool for human sarcoma circulating tumor cells.
Satelli A; Mitra A; Cutrera JJ; Devarie M; Xia X; Ingram DR; Dibra D; Somaiah N; Torres KE; Ravi V; Ludwig JA; Kleinerman ES; Li S
Cancer Res; 2014 Mar; 74(6):1645-50. PubMed ID: 24448245
[TBL] [Abstract][Full Text] [Related]
33. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
[TBL] [Abstract][Full Text] [Related]
34. Relationship between PRRX1, circulating tumor cells, and clinicopathological parameter in patients with gastric cancer.
Zhang Y; Yao J; Feng J; Wang S; Yang Z; Huang W; Da M
J BUON; 2020; 25(3):1455-1462. PubMed ID: 32862590
[TBL] [Abstract][Full Text] [Related]
35. Investigating surface proteins and antibody combinations for detecting circulating tumor cells of various sarcomas.
Le MN; Smith KA; Dopico PJ; Greer B; Alipanah M; Zhang Y; Siemann DW; Lagmay JP; Fan ZH
Sci Rep; 2024 May; 14(1):12374. PubMed ID: 38811642
[TBL] [Abstract][Full Text] [Related]
36. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.
Balasubramanian P; Lang JC; Jatana KR; Miller B; Ozer E; Old M; Schuller DE; Agrawal A; Teknos TN; Summers TA; Lustberg MB; Zborowski M; Chalmers JJ
PLoS One; 2012; 7(7):e42048. PubMed ID: 22844540
[TBL] [Abstract][Full Text] [Related]
37. Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system.
Ikeda M; Koh Y; Teraoka S; Sato K; Kanai K; Hayata A; Tokudome N; Akamatsu H; Ozawa Y; Akamatsu K; Endo K; Higuchi M; Nakanishi M; Ueda H; Yamamoto N
Cancer Med; 2020 Mar; 9(6):2122-2133. PubMed ID: 31999390
[TBL] [Abstract][Full Text] [Related]
38. Investigating the role of circulating tumor cells in gastric cancer: a comprehensive systematic review and meta-analysis.
Eskandarion MR; Eskandarieh S; Tutunchi S; Shakoori Farahani A; Shirkoohi R
Clin Exp Med; 2024 Mar; 24(1):59. PubMed ID: 38554188
[TBL] [Abstract][Full Text] [Related]
39. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
[TBL] [Abstract][Full Text] [Related]
40. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.
Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J
BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
